EUVIMEDEUVIMED entdecken
Crossref

Association between advanced fibrosis and epigenetic age acceleration among individuals with MASLD

Haili Wang iD, Zhenqiu Liu, Hong Fan, Chengnan Guo, Xin Zhang, Yi Li, Suzhen Zhao, Luojia Dai, Ming Zhao, Tiejun Zhang

Journal of Gastroenterology · 2025-03 · 60 (3) · 306-314

DOI: 10.1007/s00535-024-02181-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 20.11.2024. Verfasst von Haili Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health, Fudan University, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Epigenesis, Genetic, Aging, Fatty Liver. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Special Foundation for Science and Technology Basic Research Program, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The biological process of aging plays an important role in the progress of liver fibrosis. However, epidemiological evidence about the associations between advanced fibrosis and epigenetic age acceleration (EAA) among individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) is limited. METHODS: We utilized publicly available DNA methylation data (GSE180474) for our analysis. Five EAA measures were calculated in this study, including IEAA, PhenoAA, GrimAA, DunedinPACE, and DNAmTLAA. Separate linear regression models were conducted to explore the associations between different fibrosis grades and each measure of EAA. RESULTS: A total of 325 participants were included in this study, with a mean (± SD) age of 48.56 ± 11.50 years. Of these participants, 64.6% with no fibrosis, 16.9% with bridging fibrosis, 11.1% with incomplete cirrhosis, and 7.4% with cirrhosis. After adjusting for demographics and medication status, MASLD individuals with advanced fibrosis were associated with a 5% increase in the pace of aging (DunedinPACE, β = 0.05, 95% CI: 0.03-0.07) and a 10% decrease in DNAmTLAA (β = -0.10, 95% CI: -0.13 to -0.07) compared those without fibrosis. Similarly, higher stages of fibrosis were associated with an increased pace of aging (DunedinPACE, β = 0.02, 95% CI: 0.01-0.03, Ptrend < 0.001) and decreased DNAmTLAA (β = -0.05, 95% CI: -0.07 to -0.04, Ptrend < 0.001). However, no significant association was found between advanced fibrosis and IEAA, PhenoAA, and GrimAA. CONCLUSIONS: Our findings suggest that advanced fibrosis was associated with an accelerated pace of aging, as measured by the third-generation EA measure DunedinPACE, and shorter telomere length, captured by DNAmTLAA, among individuals with MASLD. This finding has potential prognostic implications and suggests EAA may serve as a surrogate marker of therapeutic efficacy in MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisEpigenesis, GeneticAgingFatty LiverHumansMiddle AgedMaleFemaleDNA MethylationAdultDisease Progression

Stichwörter der Autor:innen

Age accelerationEpigenetic ageFibrosisMASLD

Autor:innen und Institutionen

  • Department of Epidemiology, School of Public Health, Fudan University, Shanghai, 200032, China.
  • State Key Laboratory of Genetic Engineering, Human Phenome Institute, and School of Life Sciences, Fudan University, Shanghai, 200438, China.
  • Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, 200032, China.
  • Department of Epidemiology, School of Public Health, Fudan University, Shanghai, 200032, China. tjzhang@shmu.edu.cn.
  • Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, 200032, China. tjzhang@shmu.edu.cn.
  • Yiwu Research Institute, Fudan University, Yiwu, China. tjzhang@shmu.edu.cn.

ORCID-Profile: Haili Wang

Förderung

  • National Natural Science Foundation of China
  • Special Foundation for Science and Technology Basic Research Program
  • National Key Research and Development Program of China

Zitieren

APA

Wang, H., Liu, Z., Fan, H., Guo, C., Zhang, X., Li, Y., Zhao, S., Dai, L., Zhao, M., & Zhang, T. (2025). Association between advanced fibrosis and epigenetic age acceleration among individuals with MASLD. Journal of Gastroenterology, 60(3), 306-314. https://doi.org/10.1007/s00535-024-02181-0

Vancouver

Wang H, Liu Z, Fan H, Guo C, Zhang X, Li Y, et al. Association between advanced fibrosis and epigenetic age acceleration among individuals with MASLD. Journal of Gastroenterology. 2025;60(3):306-314. doi:10.1007/s00535-024-02181-0

BibTeX
@article{Wang2025,
  author = {Wang, Haili and Liu, Zhenqiu and Fan, Hong and Guo, Chengnan and Zhang, Xin and Li, Yi and Zhao, Suzhen and Dai, Luojia and Zhao, Ming and Zhang, Tiejun},
  title = {Association between advanced fibrosis and epigenetic age acceleration among individuals with MASLD},
  journal = {Journal of Gastroenterology},
  year = {2025},
  volume = {60},
  number = {3},
  pages = {306--314},
  doi = {10.1007/s00535-024-02181-0}
}
Kostenlos starten →